Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 12-Sep-24 8:40 PM View:  | Genelux Corp (GNLX) | 11-Sep-24 | Sale (Planned) | 1,730 | $2.60 | $4,498.87 | (4%) 49.25K to 47.52K | |
| 05-Aug-24 6:37 PM View: | Genelux Corp (GNLX) | 01-Aug-24 | Grant | 39,541 | -- | -- | 407% 9.71K to 49.25K | |
| 07-Jun-24 9:45 PM View: | Genelux Corp (GNLX) | 29-May-24 | Purchase | 6,250 | -- | -- | 181% 3.46K to 9.71K | |
| 15-Mar-24 8:01 PM View: | Assertio Holdings, Inc. (ASRT) | 14-Mar-24 | Sale | 10,251 | $1.12 | $11,462.70 | (5%) 198.5K to 188.25K | |
| 14-Dec-23 8:59 PM View: | Genelux Corp (GNLX) | 13-Dec-23 | Private Sale | 9,000 | $13.22 | $118,969.00 | (72%) 12.46K to 3.46K | |
| 13-Sep-23 8:16 PM View: | Genelux Corp (GNLX) | 11-Sep-23 | Grant | 3,460 | -- | -- | 38% 9.0K to 12.46K | |
| 12-May-23 6:34 PM View: | Assertio Holdings, Inc. (ASRT) | 10-May-23 | Grant | 31,194 | -- | -- | 19% 167.31K to 198.5K | |
| 05-May-23 9:10 PM View: | Assertio Holdings, Inc. (ASRT) | 05-May-23 | Private Sale (Planned) | 43,143 | $6.00 | $258,767.00 | (21%) 210.45K to 167.31K | |
| 02-May-23 10:00 PM View: | Genelux Corp (GNLX) | 17-Feb-23 | Grant | 9,000 | -- | -- | 100% 0 to 9.0K | |
| 24-Oct-22 7:02 PM View: | ChemoCentryx, Inc. (CCXI) | 20-Oct-22 | Disposition | 9,138 | -- | -- | (100%) 9.14K to 0 | |
| 08-Aug-22 7:27 PM View: | ChemoCentryx, Inc. (CCXI) | 04-Aug-22 | Private Sale (Planned) | 10,000 | $50.22 | $502,200.00 | (52%) 19.14K to 9.14K | |
| 13-Jun-22 6:28 PM View: | ChemoCentryx, Inc. (CCXI) | 09-Jun-22 | Sale (Planned) | 3,863 | $25.66 | $99,129.50 | (17%) 23.0K to 19.14K | |
| 24-May-22 8:18 PM View: | ChemoCentryx, Inc. (CCXI) | 20-May-22 | Option Exercise | 7,726 | -- | -- | 51% 15.28K to 23.0K | |
| 16-May-22 7:20 PM View: | Assertio Holdings, Inc. (ASRT) | 12-May-22 | Market Sale (Planned) | 44,643 | $2.36 | $105,170.00 | (18%) 255.09K to 210.45K | (27%) |
| 06-May-22 8:27 PM View: | Assertio Holdings, Inc. (ASRT) | 04-May-22 | Grant | 86,286 | -- | -- | 51% 168.81K to 255.09K | |
| 21-Dec-21 6:33 PM View: | ChemoCentryx, Inc. (CCXI) | 17-Dec-21 | Option Exercise | 37,500 | $13.22 | $495,750.00 | 245% 15.28K to 52.77K | |
| 21-Dec-21 6:33 PM View: | ChemoCentryx, Inc. (CCXI) | 17-Dec-21 | Market Option Sale (Planned) | 37,500 | $35.02 | $1,313,160.00 | (71%) 52.77K to 15.28K | |
| 24-May-21 8:19 PM View: | ChemoCentryx, Inc. (CCXI) | 21-May-21 | Option Exercise | 4,660 | -- | -- | 36% 13.07K to 17.73K | |
| 24-May-21 8:19 PM View: | ChemoCentryx, Inc. (CCXI) | 21-May-21 | Market Option Sale (Planned) | 2,454 | $9.76 | $23,955.90 | (14%) 17.73K to 15.28K | |
| 13-May-21 5:27 PM View: | Assertio Holdings, Inc. (ASRT) | 11-May-21 | Grant | 357,143 | -- | -- | 112% 318.09K to 675.23K | |
| 26-May-20 8:59 PM View: | ChemoCentryx, Inc. (CCXI) | 23-May-20 | Option Exercise | 7,724 | -- | -- | 145% 5.34K to 13.07K | |
| 21-May-20 9:05 PM View: | Assertio Holdings, Inc. (ASRT) | 19-May-20 | Grant | 237,500 | -- | -- | 295% 80.59K to 318.09K | |
| 15-Jan-20 6:23 PM View: | ChemoCentryx, Inc. (CCXI) | 13-Jan-20 | Market Sale (Planned) | 30,000 | $37.06 | $1,111,690.00 | (85%) 35.34K to 5.34K | 72% |
| 23-May-19 9:20 PM View: | ChemoCentryx, Inc. (CCXI) | 21-May-19 | Option Exercise | 8,421 | -- | -- | 31% 26.92K to 35.34K | |
| 09-May-19 11:31 AM View: | DepoMed Inc. (ASRT) | 08-May-19 | Option Exercise | 31,250 | -- | -- | 63% 49.34K to 80.59K | |
| 09-May-19 11:31 AM View: | DepoMed Inc. (ASRT) | 07-May-19 | Grant | 39,584 | -- | -- | 406% 9.76K to 49.34K | |
| 14-Feb-19 10:00 PM View: | DepoMed Inc. (ASRT) | 15-May-18 | Option Exercise | 19,512 | -- | -- | (200%) (-9.76K) to 9.76K | |
| 30-May-17 7:02 PM View: | ChemoCentryx, Inc. (CCXI) | 26-May-17 | Option Exercise | 20,362 | -- | -- | 61% 33.49K to 53.85K | |
| 30-May-17 7:02 PM View: | ChemoCentryx, Inc. (CCXI) | 25-May-17 | Grant | 12,912 | -- | -- | 63% 20.57K to 33.49K | |
| 24-Apr-17 5:05 PM View: | Theravance Inc. (INVA) | 20-Apr-17 | Grant | 19,857 | -- | -- | 39% 50.7K to 70.55K | |
| 24-May-16 7:06 PM View: | ChemoCentryx, Inc. (CCXI) | 23-May-16 | Market Option Sale (Planned) | 5,544 | $4.39 | $24,337.10 | (21%) 26.12K to 20.57K | (138%) |
| 24-May-16 7:06 PM View: | ChemoCentryx, Inc. (CCXI) | 21-May-16 | Option Exercise | 11,795 | -- | -- | 82% 14.32K to 26.12K | |
| 20-May-16 7:50 PM View: | Theravance Inc. (INVA) | 18-May-16 | Market Sale (Planned) | 813 | $10.47 | $8,512.11 | (2%) 51.51K to 50.7K | (18%) |
| 27-Apr-16 4:52 PM View: | Theravance Inc. (INVA) | 26-Apr-16 | Grant | 18,328 | -- | -- | 51% 35.62K to 53.95K | |
| 04-Jun-15 4:12 PM View: | Theravance Inc. (INVA) | 02-Jun-15 | Market Sale (Planned) | 2,438 | $16.85 | $41,080.30 | (7%) 35.62K to 33.18K | 25% |
| 26-May-15 5:31 PM View: | ChemoCentryx, Inc. (CCXI) | 22-May-15 | Option Exercise | 27,027 | -- | -- | 100% 0 to 27.03K | |
| 26-May-15 5:31 PM View: | ChemoCentryx, Inc. (CCXI) | 22-May-15 | Market Option Sale (Planned) | 12,703 | $7.45 | $94,592.90 | (47%) 27.03K to 14.32K | (40%) |
| 27-Apr-15 6:31 PM View: | Theravance Inc. (INVA) | 24-Apr-15 | Grant | 13,950 | -- | -- | 64% 21.67K to 35.62K | |
| 23-Dec-14 4:31 PM View: | Theravance Inc. (INVA) | 22-Dec-14 | Grant | 6,500 | -- | -- | 43% 15.17K to 21.67K | |
| 04-Jun-14 8:04 PM View: | Theravance Inc. (INVA) | 02-Jun-14 | Grant | 12,000 | -- | -- | 100% 0 to 12.0K | |
| 03-Mar-09 7:17 PM View: | Abbott Laboratories (ABT) | 27-Feb-09 | Payment of Exercise | 6,813 | $50.58 | $344,602.00 | (5%) 150.64K to 143.83K | (445%) |
| 03-Mar-09 7:17 PM View: | Abbott Laboratories (ABT) | 27-Feb-09 | Market Sale | 10,454 | $47.68 | $498,458.00 | (7%) 143.83K to 133.38K | (478%) |
| 24-Feb-09 5:05 PM View: | Abbott Laboratories (ABT) | 20-Feb-09 | Grant | 45,800 | -- | -- | 44% 104.84K to 150.64K | |
| 19-Feb-09 12:16 PM View: | Abbott Laboratories (ABT) | 17-Feb-09 | Payment of Exercise | 3,268 | $54.94 | $179,544.00 | (3%) 113.67K to 110.4K | (402%) |
| 19-Feb-09 12:16 PM View: | Abbott Laboratories (ABT) | 17-Feb-09 | Market Sale | 5,565 | $54.09 | $301,030.00 | (5%) 110.4K to 104.83K | (410%) |
| 04-Feb-09 9:55 PM View: | Abbott Laboratories (ABT) | 02-Feb-09 | Option Exercise | 98,831 | $46.02 | $4,548,220.00 | 204% 48.48K to 147.31K | 24% |
| 04-Feb-09 9:55 PM View: | Abbott Laboratories (ABT) | 02-Feb-09 | Market Sale | 74,089 | $54.75 | $4,056,300.00 | (61%) 121.38K to 47.29K | (404%) |
| 04-Feb-09 9:55 PM View: | Abbott Laboratories (ABT) | 02-Feb-09 | Market Option Sale | 88,975 | $54.93 | $4,887,780.00 | (60%) 147.31K to 58.33K | (402%) |
| 18-Nov-08 5:00 PM View: | Abbott Laboratories (ABT) | 14-Nov-08 | Payment of Exercise | 911 | $57.14 | $52,054.50 | (< 1%) 123.47K to 122.56K | (386%) |
| 18-Nov-08 5:00 PM View: | Abbott Laboratories (ABT) | 14-Nov-08 | Option Exercise | 1,040 | $45.45 | $47,266.80 | < 1% 122.43K to 123.47K | 26% |